LINKÖPING, Sweden, March 5, 2026 – This March 10-12th, AMRA Medical is pleased to be attending the 16th Intrinsic Capacity, Frailty and Sarcopenia Research Conference for Healthy Longevity (ICFSR 2026), in Washington, DC! This year, our team is excited to contribute to the conversation and share findings from two studies using our MRI-based muscle assessment biomarkers in sarcopenia and frailty research.
The first poster presentation (Poster #178), titled “Muscle abnormalities in heart failure detected using MRI-based muscle composition”, done in collaboration with Dr. Javed Butler at the Baylor Scott & White Research Institute and Linköping University, aimed at describing muscle composition and prevalence of adverse muscle composition (AMC) and sarcopenia in 185 participants with heart failure (HF) based on the UK Biobank imaging study. The results showed HF participants had a two-fold higher prevalence of AMC compared to matched controls and demonstrated weaker grip strength, suggesting possible functional impairment. However, sarcopenia was not more common in the HF group indicating current diagnostic criteria may under-detect early or subclinical muscle abnormalities in HF.
Our second study (Poster #184), “Can normative data for muscle ageing be inferred from cross-sectional cohort data? A large scale investigation using longitudinal UK Biobank imaging data”, determined the 5-year change in muscle composition based across women and men in different age and BMI groups. The study also compared actual changes in muscle composition to changes inferred from cross-sectional data. The results showed that muscle composition appeared to worsen faster with older age (particularly in men), and a higher rate of thigh muscle mass loss could be observed with higher BMI. These patterns were only partly observed through changes inferred from cross-sectional data, which were generally underestimated compared to actual changes.
For more than a decade, the International Conference on Frailty and Sarcopenia Research (ICFSR) has grown into a leading global forum dedicated to accelerating clinical research and translational science focused on aging populations. AMRA is proud to be at the forefront of these discussions, helping to demonstrate how much more we can learn from detailed assessments of muscle composition such as MRI-based measures and biomarkers.
If you’ll be in DC for ICFSR 2026, make sure to connect with us and learn more about our science! You can reach out at info@amramedical.com to set up a meeting with one of our team members to discuss how AMRA’s MRI-based fat and muscle biomarkers can help transform your trials in sarcopenia, muscle wasting, and beyond. We can’t wait to see you in DC!